Abstract
Seventeen patients with mycoplasmal pneumonia were administered intravenous minocycline, a tetracycline antibiotic with long-acting effects. Excellent therapeutic effects were observed both clinically and bacteriologically. The organism was eliminated in a shorter period of time compared to other antibiotics used for the treatment ofMycoplasma pneumoniae infections. Aside from 1 patient who experienced nausea and vomiting and was taken off minocycline, no other adverse effects were noted in these patients. Minocycline should be strongly considered as therapy for mycoplasmal pneumonia because it may completely eradicate the organism within 7 days.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
